SETD2 mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemia

References

• Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a children’s oncology group study. Leukemia. 2008;22(12):2142–2150. doi:10.1038/leu.2008.251
   PubMed Web of Science ®Google Scholar
• Yang JJ, Bhojwani D, Yang W, et al. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood. 2008;112(10):4178–4183. doi:10.1182/blood-2008-06-165027
   PubMed Web of Science ®Google Scholar
• Hogan LE, Meyer JA, Yang J, et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011;118(19):5218–5226. doi:10.1182/blood-2011-04-345595
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Phillips LA, Su X, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008;322(5906):1377–1380. doi:10.1126/science.1164266
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Zhang J, Kasper LH, et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature. 2011;471(7337):235–239. doi:10.1038/nature09727
   PubMed Web of Science ®Google Scholar
• Ma X, Edmonson M, Yergeau D, et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. 2015;6(1):6604. doi:10.1038/ncomms7604
   PubMedGoogle Scholar
• Meyer JA, Wang J, Hogan LE, et al. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nat Genet. 2013;45(3):290–294. doi:10.1038/ng.2558
   PubMed Web of Science ®Google Scholar
• Evensen NA, Madhusoodhan PP, Meyer J, et al. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Haematologica. 2018;103(5):830–839. doi:10.3324/haematol.2017.176362
   PubMed Web of Science ®Google Scholar
• Jones CL, Bhatla T, Blum R, et al. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model. J Biol Chem. 2014;289(30):20502–20515. doi:10.1074/jbc.M114.569889
   PubMed Web of Science ®Google Scholar
• Mar BG, Bullinger LB, McLean KM, et al. Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. Nat Commun. 2014;5(1):3469. doi:10.1038/ncomms4469
   PubMedGoogle Scholar
• Zhu X, He F, Zeng H, et al. Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat Genet. 2014;46(3):287–293. doi:10.1038/ng.2894
   PubMed Web of Science ®Google Scholar
• Chen BY, Song J, Hu CL, et al. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS. Blood. 2020;135(25):2271–2285. doi:10.1182/blood.2019001963
   PubMed Web of Science ®Google Scholar
• Liu H. SETD2 detection may reveal response to induction therapy and survival profile in acute myeloid leukemia patients. Hematology. 2023;28(1):2161194. doi:10.1080/16078454.2022.2161194
   PubMed Web of Science ®Google Scholar
• Xie Y, Sahin M, Sinha S, et al. SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes. Nat Cancer. 2022;3(2):188–202. doi:10.1038/s43018-021-00316-3
   PubMedGoogle Scholar
• Wang S, Yuan X, Liu Y, et al. Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in chinese acute myeloid leukemia patients. J Transl Med. 2019;17(1):101. doi:10.1186/s12967-019-1848-9
   PubMedGoogle Scholar
• Lam UTF, Chen ES. Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase. Int J Biochem Cell Biol. 2022;144:106155. doi:10.1016/j.biocel.2021.106155
   PubMed Web of Science ®Google Scholar
• Mar BG, Chu SH, Kahn JD, et al. SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia. Blood. 2017;130(24):2631–2641. doi:10.1182/blood-2017-03-775569
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhao X, Feng X, et al. SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints. Leukemia. 2019;33(11):2585–2598. doi:10.1038/s41375-019-0456-2
   PubMed Web of Science ®Google Scholar
• Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11(8):783–784. doi:10.1038/nmeth.3047
   PubMed Web of Science ®Google Scholar
• Carvalho S, Vitor AC, Sridhara SC, et al. SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint. Elife. 2014;3:e02482. doi:10.7554/eLife.02482
   PubMed Web of Science ®Google Scholar
• Pierro J, Saliba J, Narang S, et al. The NSD2 p.E1099K mutation is enriched at relapse and confers drug resistance in a cell Context-Dependent manner in pediatric acute lymphoblastic leukemia. Mol Cancer Res. 2020;18(8):1153–1165. doi:10.1158/1541-7786.MCR-20-0092
   PubMed Web of Science ®Google Scholar
• Sewe SO, Silva G, Sicat P, et al. Trimming and validation of illumina short reads using trimmomatic, Trinity assembly, and assessment of RNA-Seq data. Methods Mol Biol. 2022;2443:211–232.
   PubMedGoogle Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi:10.1093/bioinformatics/btu170
   PubMed Web of Science ®Google Scholar
• Li H. Exploring single-sample SNP and INDEL calling with whole-genome de novo assembly. Bioinformatics. 2012;28(14):1838–1844. doi:10.1093/bioinformatics/bts280
   PubMed Web of Science ®Google Scholar
• Tarasov A, Vilella AJ, Cuppen E, et al. Sambamba: fast processing of NGS alignment formats. Bioinformatics. 2015;31(12):2032–2034. doi:10.1093/bioinformatics/btv098
   PubMed Web of Science ®Google Scholar
• De Summa S, Malerba G, Pinto R, et al. GATK hard filtering: tunable parameters to improve variant calling for next generation sequencing targeted gene panel data. BMC Bioinformatics. 2017;18(Suppl 5):119. doi:10.1186/s12859-017-1537-8
   PubMedGoogle Scholar
• Brouard JS, Schenkel F, Marete A, et al. The GATK joint genotyping workflow is appropriate for calling variants in RNA-seq experiments. J Anim Sci Biotechnol. 2019;10:44.
   PubMed Web of Science ®Google Scholar
• Saunders CT, Wong WS, Swamy S, et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012;28(14):1811–1817. doi:10.1093/bioinformatics/bts271
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. doi:10.1093/bioinformatics/bts635
   PubMed Web of Science ®Google Scholar
• Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–930. doi:10.1093/bioinformatics/btt656
   PubMed Web of Science ®Google Scholar
• Ramirez F, Dundar F, Diehl S, et al. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 2014;42(Web Server issue):W187–91. doi:10.1093/nar/gku365
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Chen EY, Tan CM, Kou Y, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14(1):128. doi:10.1186/1471-2105-14-128
   PubMed Web of Science ®Google Scholar
• Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–7. doi:10.1093/nar/gkw377
   PubMed Web of Science ®Google Scholar
• Buenrostro JD, Wu B, Chang HY, et al. ATAC-seq: a method for assaying chromatin accessibility Genome-Wide. Curr Protoc Mol Biol. 2015;109(21):21.29.1–21 29 9.
   PubMedGoogle Scholar
• Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nat Methods. 2012;9(4):357–359. doi:10.1038/nmeth.1923
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu T, Meyer CA, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9(9):R137. doi:10.1186/gb-2008-9-9-r137
   PubMed Web of Science ®Google Scholar
• Ross-Innes CS, Stark R, Teschendorff AE, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481(7381):389–393. doi:10.1038/nature10730
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, He QY. ChIPseeker: an R/bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31(14):2382–2383. doi:10.1093/bioinformatics/btv145
   PubMed Web of Science ®Google Scholar
• Bu J, Chen A, Yan X, et al. SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. Leukemia. 2018;32(4):890–899. doi:10.1038/leu.2017.339
   PubMed Web of Science ®Google Scholar
• Jones CL, Gearheart CM, Fosmire S, et al. MAPK signaling Cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia. Blood. 2015;126(19):2202–2212. doi:10.1182/blood-2015-04-639138
   PubMed Web of Science ®Google Scholar
• Daugaard M, Baude A, Fugger K, et al. LEDGF (p75) promotes DNA-end resection and homologous recombination. Nat Struct Mol Biol. 2012;19(8):803–810. doi:10.1038/nsmb.2314
   PubMed Web of Science ®Google Scholar
• Li F, Mao G, Tong D, et al. The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSalpha. Cell. 2013;153(3):590–600. doi:10.1016/j.cell.2013.03.025
   PubMed Web of Science ®Google Scholar
• Leung W, Teater M, Durmaz C, et al. SETD2 haploinsufficiency enhances germinal Center-Associated AICDA somatic hypermutation to drive B-cell lymphomagenesis. Cancer Discov. 2022;12(7):1782–1803. doi:10.1158/2159-8290.CD-21-1514
   PubMed Web of Science ®Google Scholar
• Masetti R, Castelli I, Astolfi A, et al. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing. Oncotarget. 2016;7(35):56746–56757. doi:10.18632/oncotarget.10778
   PubMedGoogle Scholar
• Lu M, Zhao B, Liu M, et al. Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy. NPJ Precis Oncol. 2021;5(1):51. doi:10.1038/s41698-021-00193-0
   PubMed Web of Science ®Google Scholar
• Yang F, Brady SW, Tang C, et al. Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse. Nat Cancer. 2021;2(8):819–834. doi:10.1038/s43018-021-00230-8
   PubMedGoogle Scholar
• Xie Y, Sahin M, Wakamatsu T, et al. SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis. JCI Insight. 2023;8(4):e154120. doi:10.1172/jci.insight.154120
   PubMed Web of Science ®Google Scholar
• Simon JM, Hacker KE, Singh D, et al. Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects. Genome Res. 2014;24(2):241–250. doi:10.1101/gr.158253.113
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yan X, Feng X, et al. Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation. Haematologica. 2018;103(7):1110–1123. doi:10.3324/haematol.2018.187708
   PubMed Web of Science ®Google Scholar
• Zhu L, Li Q, Wong SH, et al. ASH1L links histone H3 lysine 36 dimethylation to MLL leukemia. Cancer Discov. 2016;6(7):770–783. doi:10.1158/2159-8290.CD-16-0058
   PubMed Web of Science ®Google Scholar
• Edmunds JW, Mahadevan LC, Clayton AL. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. Embo J. 2008;27(2):406–420. doi:10.1038/sj.emboj.7601967
   PubMed Web of Science ®Google Scholar
• Skucha A, Ebner J, Grebien F. Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond. Int J Mol Sci. 2019;20(5):1029.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu L, Qu Y, et al. Prognostic value of SETD2 expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. J Urol. 2016;196(5):1363–1370. doi:10.1016/j.juro.2016.06.010
   PubMed Web of Science ®Google Scholar
• Parker H, Rose-Zerilli MJ, Larrayoz M, et al. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia. Leukemia. 2016;30(11):2179–2186. doi:10.1038/leu.2016.134
   PubMed Web of Science ®Google Scholar
• Zhang YL, Sun JW, Xie YY, et al. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation. Cell Res. 2018;28(4):476–490. doi:10.1038/s41422-018-0015-9
   PubMed Web of Science ®Google Scholar
• Sessa A, Fagnocchi L, Mastrototaro G, et al. SETD5 regulates chromatin methylation state and preserves global transcriptional fidelity during brain development and neuronal wiring. Neuron. 2019;104(2):271–289 e13. doi:10.1016/j.neuron.2019.07.013
   PubMed Web of Science ®Google Scholar
• Xie P, Tian C, An L, et al. Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes. Cell Signal. 2008;20(9):1671–1678. doi:10.1016/j.cellsig.2008.05.012
   PubMed Web of Science ®Google Scholar
• Xiao H, Wang LM, Luo Y, et al. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation. Oncotarget. 2016;7(3):2696–2708. doi:10.18632/oncotarget.6259
   PubMedGoogle Scholar
• Li B, Brady SW, Ma X, et al. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Blood. 2020;135(1):41–55. doi:10.1182/blood.2019002220
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675. doi:10.1038/nmeth.2089
   PubMed Web of Science ®Google Scholar